Ambit Biosciences Announces Third Quarter 2013 Operating Results
Published: Nov 08, 2013
SAN DIEGO, Nov. 7, 2013 -- SAN DIEGO, Nov. 7, 2013 /PRNewswire/ -- Ambit Biosciences (NASDAQ: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced third quarter and year-to-date operating results for 2013.
Help employers find you! Check out all the jobs and post your resume.